Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue 3, 2014, Pages 333-339

  Yehia, Baligh R ^a,b,c   French, Benjamin ^d   Fleishman, John A ^e   Metlay, Joshua P ^f   Berry, Stephen A ^g   Korthuis, P Todd ^h   Agwu, Allison L ^g   Gebo, Kelly A ^g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CD4 count; engagement in care; HIV disease severity; retention in care; retention measures; viral suppression

Indexed keywords

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; UNITED STATES; VIRAL LOAD; YOUNG ADULT;

EID: 84894505585     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000023     Document Type: Conference Paper

References (34)

1. Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. 2011;60:1618-1623
2. Fleishman JA, Yehia BR, Moore RD, et al. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr. 2012;60:249-259
3. Mugavero MJ. Improving engagement in HIV care: What can we do? Top HIV Med. 2008;16:156-161
4. Horstmann E, Brown J, Islam F, et al. Retaining HIV-infected patients in care: Where are we? Where do we go from here? Clin Infect Dis. 2010; 50:752-761
5. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23:41-49
6. Berg MB, Safren SA, Mimiaga MJ, et al. Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care. 2005;17:902-907
7. Giordano TP, White AC Jr, Sajja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003;32:399-405
8. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131:81-87
9. Mugavero MJ, Lin HY, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48:248-256
10. Metsch LR, Pereyra M, Messinger S, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis. 2008;47:577-584
11. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: Evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012; 156:817-833
12. Yehia BR, Kangovi S, Frank I. Patients in transition: Avoiding detours on the road to HIV treatment success. AIDS. Epub ahead of print Feb 21, 2013
13. Yehia BR, Fleishman JA, Moore RD, et al. Retention in care and health outcomes of transgender persons living with HIV. Clin Infect Dis. Epub ahead of print June 23, 2013
14. MugaveroMJ,Westfall AO, Zinski A, et al.Measuring retention in HIV care: The elusive gold standard. J Acquir Immune Defic Syndr. 2012;61:574-580
15. Mugavero MJ, Amico KR, Westfall AO, et al. Early retention in HIV care and viral load suppression: Implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr. 2012;59:86-93
16. Tripathi A, Youmans E, Gibson JJ, et al. The impact of retention in early HIV medical care on viro-immunological parameters and survival: A statewide study. AIDS Res Hum Retroviruses. 2011;27:751-758
17. Giordano TP, Gifford AL,White AC Jr, et al. Retention in care: A challenge to survival with HIV infection. Clin Infect Dis. 2007;44:1493-1499
18. Mohammadpour A, Yekta ZP, Nikbakht Nasrabadi AR. HIV-infected patients' adherence to highly active antiretroviral therapy: A phenomenological study. Nurs Health Sci. 2010;12:464-469
19. Prosperi MC, Fabbiani M, Fanti I, et al. Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: A retrospective cohort study. BMC Infect Dis. 2012;12:296
20. Remien RH, Hirky AE, Johnson MO, et al. Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav. 2003;7:61-72
21. Yehia BR, Gebo KA, Hicks PB, et al. Structures of care in the clinics of the HIV Research Network. AIDS Patient Care STDS. 2008;22:1007-1013
22. Yehia BR, Agwu AL, Schranz A, et al. Conformity of pediatric/adolescent HIV clinics to the patient-centered medical home care model. AIDS Patient Care STDS. 2013;27:272-279
23. Yehia BR, Fleishman JA, Metlay JP, et al. Comparing different measures of retention in outpatient HIV care. AIDS. 2012;26:1131-1139
24. Health Resources and Services Administration. HAB HIV core clinical performance measures for adult/adolescent clients: Group 1-medical visits. 2008. Available at: Http://hab.hrsa.gov/deliverhivaidscare/files/ habgrp1pms08.pdf. Accessed May 15, 2013
25. Mancl LA, Leroux BG. Efficiency of regression estimates for clustered data. Biometrics. 1996;52:500-511
26. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130
27. Nemes MI, Carvalho HB, Souza MF. Antiretroviral therapy adherence in Brazil. AIDS. 2004;18(suppl 3):S15-S20
28. Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-Antiretroviral therapies in the multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82-92
29. Mallinson RK, Relf MV, Dekker D, et al. Maintaining normalcy: A grounded theory of engaging in HIV-oriented primary medical care. ANS Adv Nurs Sci. 2005;28:265-277
30. Marzolini C, Elzi L, Gibbons S, et al. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther. 2010;15:413-423
31. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescent. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2010. Available at: Http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl. pdf. Accessed April 25, 2013
32. Mukolo A, Villegas R, Aliyu M, et al. Predictors of late presentation for HIV diagnosis: A literature review and suggested way forward. AIDS Behav. 2013;17:5-30
33. Beach MC, Keruly J, Moore RD. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med. 2006;21:661-665
34. Giordano TP, Visnegarwala F, White AC Jr, et al. Patients referred to an urban HIV clinic frequently fail to establish care: Factors predicting failure. AIDS Care. 2005;17:773-783